{
  "paper_id": "PMC9378633",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378633/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1. Characterization of a population of non-cycling PROM1+ cells in pediatric glioblastomas.",
      "caption": "a UMAP representation 7930 cells, profiled with single cell RNA-seq from 28 glioblastomas in Ref. 15. Malignant cells are highlighted. Cells from adult and pediatric glioblastomas, 5742 and 2188 respectively, are color-coded. b Distributions of PROM1 expression in adult and pediatric glioblastoma malignant cells (n = 4916 adult malignant cells; n = 1947 pediatric malignant cells). Differences in the distributions were tested with two-tailed Wilcoxon rank-sum test. c UMAP representation of glioblastoma malignant cells, color-coded according to PROM1 expression. d UMAP representation of cycling and non-cycling glioblastoma malignant cells (3671 and 3192, respectively). e Percentage of non-cycling PROM1+ cells among malignant cells of adult and pediatric glioblastomas. Pediatric non-cycling PROM1+ cells were further classified according to the expression of SOX2 and OLIG2 into four subpopulations. f Schematic representations of the comparisons performed to characterize specific subpopulations of malignant cells from pediatric glioblastomas: among non-cycling cells, 313 PROM1+ cells were compared to 548 PROM1- cells (PROM1+ vs PROM1-). Among PROM1+ cells, 313 non-cycling and 523 cycling cells were compared (non-cycling vs cycling). g Number of marker genes identified by comparing non-cycling PROM1+ vs PROM1- cells (top bar) and cycling vs non-cycling PROM1+ cells (bottom bar). h Gene Ontology enrichment analysis of marker genes more expressed in cycling PROM1+ cells when compared to non-cycling cells (n = 313 non-cycling pediatric PROM1+ malignant cells; n = 523 cycling pediatric PROM1+ malignant cells) (one-sided Fisher’s exact test). i Gene Ontology enrichment analysis of marker genes more expressed in non-cycling PROM1+ cells when compared to PROM1- cells (n = 313 non-cycling pediatric PROM1+ malignant cells; n = 548 non-cycling pediatric PROM1- malignant cells) (one-sided Fisher’s exact test).",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/b22f8c4f9794/41467_2022_32448_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/b22f8c4f9794/41467_2022_32448_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/b22f8c4f9794/41467_2022_32448_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/b22f8c4f9794/41467_2022_32448_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/b22f8c4f9794/41467_2022_32448_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9378633/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/b22f8c4f9794/41467_2022_32448_Fig1_HTML.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. 2. Direct visualization of quiescent Prom1+ cells in the brain tumor of mice.",
      "caption": "a Electroporation of cells in the SVZ of P2 CD1 mice with pPB-CAG-TPR-MET-ires-mCherry and pPB-CAG-p53R273C-ires-mCherry (TP-Cherry) together with pPB-mProm1-mVenus-p27K− (Prom1-Venus-p27). Mice were sacrificed at humane endpoint. b Survival curve (p = 0.0001) of mice injected with only TPR-MET (n = 7 mice, black line) or both TPR-MET and p53R273C (n = 7 mice, blue line). c Mosaic images of brain sections showing Prom1-Venus-p27 expressing cells within the tumor (mCherry+) (n = 10 mice). d, e Images (d) and quantifications (e) of mVenus+ cells (green) not expressing Ki67 (red) in the core and edge/infiltrative regions of the mCherry+ tumors expressing Prom1-Venus-p27 (n = 4 mice, 4818 cells). Each dot represents a brain section. f, g Images (f) and quantifications (g) of mVenus+ cells (green) labeled with EdU (red) (n = 2 mice, 429 cells). Cells in the SVZ of P2 CD1 mice were electroporated with pPB-CAG-TPR-MET-ires-mCherry and pPB-CAG-p53R273C-ires-mCherry (TP-Cherry) together with pPB-mProm1-mVenus-p27K− (Prom1-Venus-p27). Mice were injected with EdU at P44 and brains were dissected at P45. h, i Images (h) and quantifications (i) of mVenus+ cells (green) expressing SOX2 (red) in the core and edge/infiltrative regions of the mCherry+ tumors expressing Prom1-Venus-p27 (n = 3 mice, 1966 cells). j, k Images (j) and quantifications (k) of mVenus+ cells (green) expressing OLIG2 (red) in the core and edge/infiltrative regions of the mCherry+ tumors expressing Prom1-Venus-p27 (for core n = 4 mice, 3753 cells; for infiltrating edge n = 4 mice, 1104 cells). l Images of mVenus+ cells (green) co-expressing N-cadherin (gray) in the core or edge/infiltrative areas of the mCherry+ tumors (red) expressing Prom1-Venus-p27 (n = 6 mice). N-cadherin expression level is shown as multi-colored LUT fire. Asterisks refer to Venus-p27 expressing cells. Scale bars (c) 2 mm, (d, f, h, j, l) 100 μm, (l, ROI) 50 μm, (j, ROI) 40 μm. Data are presented as mean ± SEM. P values are calculated by unpaired two-tailed non-parametric Mann–Whitney test (k). Kaplan–Meier survival curve followed by Log-rank (Mantel–Cox) test was used for testing difference in the survival of mice (b). Source data are provided as a Source Data file.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e96c90625b46/41467_2022_32448_Fig2_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e96c90625b46/41467_2022_32448_Fig2_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e96c90625b46/41467_2022_32448_Fig2_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e96c90625b46/41467_2022_32448_Fig2_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e96c90625b46/41467_2022_32448_Fig2_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9378633/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e96c90625b46/41467_2022_32448_Fig2_HTML.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Fig. 3. Lineage tracing of quiescent Prom1+ cells in TP-induced tumors after Temozolomide treatment.",
      "caption": "a Electroporation of cells in the SVZ of P2 CD1 mice with pPB-CAG-TPR-MET-ires-mCherry and pPB-CAG-p53R273C-ires-mCherry together with pPB-CAG-LSL-mVenus and pPB-mProm1-CreERT2-p27K−. Mice were injected with DMSO or Temozolomide (TMZ) every day from P30 to P34 and then with Tamoxifen every two days from P35 to P41. Brains were dissected at P42 and P56. b Quantification of the tumor size shown as percentage of mCherry+ area over DAPI+ area in brain sections of DMSO- (n = 7 mice at P42; n = 3 mice at P56) and TMZ-treated (n = 7 mice at P42; n = 5 mice at P56). Each dot represents a brain section. c Quantification of mVenus+ infiltrating cells in the tumor of DMSO- (n = 7 mice at P42; n = 3 mice at P56) and TMZ-treated (n = 7 mice at P42; n = 5 mice at P56). Each dot represents a brain section. d, e Images (d) and quantifications (e) of mVenus+ cells (green) co-expressing Ki67 (gray) in the core or edge/infiltrative regions of the mCherry+ tumors (red) of DMSO- (n = 6 mice at P42, 576 cells for core and 380 cells for infiltrating edge; n = 3 mice at P56, 219 cells for core and 85 cells for infiltrating edge) and TMZ-treated (n = 7 mice at P42, 613 cells for core and 1058 cells for infiltrating edge; n = 5 mice at P56, 952 cells for core and 82 cells for infiltrating edge). Each dot represents a tumor area. f, g Images (f) and quantifications (g) of mVenus+ cells (green) co-expressing OLIG2 (gray) in the core or edge/infiltrative areas of the mCherry+ tumors (red) of DMSO- (n = 6 mice at P42, 736 cells for core and 447 cells for infiltrating edge; n = 3 mice at P56, 237 cells for core and 123 cells for infiltrating edge) and TMZ-treated (n = 7 mice at P42, 722 cells for core and 527 cells for infiltrating edge; n = 5 mice at P56, 1620 cells for core and 229 cells for infiltrating edge). Scale bars (d, f) 100 μm. Data are presented as mean ± SEM. p values calculated by Kruskal–Wallis test followed by Dunn’s test for multiple comparison (b, c, d). Source data are provided as a Source Data file.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e61c70a6e6e9/41467_2022_32448_Fig3_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e61c70a6e6e9/41467_2022_32448_Fig3_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e61c70a6e6e9/41467_2022_32448_Fig3_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e61c70a6e6e9/41467_2022_32448_Fig3_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e61c70a6e6e9/41467_2022_32448_Fig3_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9378633/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/e61c70a6e6e9/41467_2022_32448_Fig3_HTML.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Fig. 4. Ablation of quiescent Prom1+ cells reduces infiltration in TP-induced tumors.",
      "caption": "a Electroporation of cells in the SVZ of P2 CD1 mice with pPB-CAG-TPR-MET-ires-mCherry, pPB-CAG-p53R273C-ires-mCherry and pPB-mProm1-mVenus-p27K− with or without pPB-mProm1-DTA-p27K−. b Images of brain sections showing Prom1-Venus-p27 expressing cells within the tumor (mCherry+) of mice co-electroporated without (n = 5 mice) or with (n = 5 mice) pPB-mProm1-DTA-p27K− (Prom1-DTA-p27). c Survival curve of mice injected with pPB-CAG-TPR-MET-ires-mCherry, pPB-CAG-p53R273C-ires-mCherry and pPB-mProm1-mVenus-p27K− without (n = 23 mice) or with pPB-mProm1-DTA-p27K− (n = 18 mice). d, e Quantifications of mVenus+ (green) (d) and mCherry+ (red) (e) area in the brain sections of mice co-electroporated without (n = 5 mice) or with (n = 5 mice) Prom1-DTA-p27. Each dot represents a brain section and color code is applied to each mouse. f Quantification of the distance of the infiltrated mCherry+ cells from the tumor edge in the brain sections of mice co-electroporated without (n = 5 mice) or with (n = 5 mice) Prom1-DTA-p27. The furthest 3 cells for each section were considered; each dot represents a cell and color code is applied to each mouse. g Electroporation of cells in the SVZ of P2 CD1 mice with pPB-CAG-TPR-MET-ires-mCherry, pPB-CAG-p53R273C-ires-mCherry, pPB-mProm1-mVenus-p27K−, pPB-mProm1-CreERT2-p27K− and pPB-CAG-LSL-DTA. Mice were injected with Tamoxifen every two days from P17 to P45. h–j, Images (h) and quantifications of mVenus+ (green) (i) and mCherry+ (red) (j) area in the brain sections of mice un-injected (n = 4) or injected (n = 4 mice) with Tamoxifen (Tam). Each dot represents a brain section and color code is applied to each mouse. k Quantification of the distance of the infiltrated mCherry+ or mVenus+ cells from the tumor edge in the brain sections of mice un-injected (n = 4 mice) or injected (n = 4 mice) with Tamoxifen. The furthest 3 cells for each section were considered; each dot represents a cell and color code is applied to each mouse. Scale bars (b, h) 2 mm. Data are presented as mean ± SEM. P values were calculated by unpaired two-tailed non-parametric Mann–Whitney test (d, e, f, i, k) or unpaired two-tailed Student’s t test (j). Kaplan–Meier survival curve followed by Log-rank (Mantel-Cox) test was used for testing difference in the survival of mice (b). Source data are provided as a Source Data file.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/9ef554a012d3/41467_2022_32448_Fig4_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/9ef554a012d3/41467_2022_32448_Fig4_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/9ef554a012d3/41467_2022_32448_Fig4_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/9ef554a012d3/41467_2022_32448_Fig4_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/9ef554a012d3/41467_2022_32448_Fig4_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9378633/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/9ef554a012d3/41467_2022_32448_Fig4_HTML.jpg"
    },
    "figure_5": {
      "figure_number": "Figure 5",
      "title": "Fig. 5. Direct visualization and targeting of infiltrating quiescent cells in human brain cancer organoids.",
      "caption": "a Scheme of the differentiation protocol of hiPSCs in forebrain organoids. At day 35 organoids were electroporated with pPB-CAG-mCherry (Cherry) or pPB-CAG-TPR-MET-ires-mCherry and pPB-CAG-p53R273C-ires-mCherry (TP-Cherry) and cultured for additional 30 days (30 dpe). b Images of electroporated organoids at 30 dpe (n = 7 organoids per type). c, d Images (c) and quantifications (d) of mCherry+ cells (red) co-expressing Ki67 (green) in organoids at 30 dpe electroporated with Cherry or TP-Cherry (n = 4 Cherry organoids, 368 cells; n = 6 TP-Cherry organoids, 1355 cells). Each dot represents an organoid section. e Electroporation of D35 organoids with pPB-CAG-TPR-MET-ires-mCherry, pPB-CAG-p53R273C-ires-mCherry and pPB-CAG-mVenus-p27K− (TP-cherry/Venus-p27). Organoids were fixed at 30 dpe. f, g Images (f) and quantifications (g) of mVenus+ cells (green) not expressing Ki67 (red) in TP-Cherry/Venus-p27 organoids at 30 dpe (n = 8 organoids, 298 cells). h Grafting of TP-Cherry/Venus-p27 organoids in the brains of nude mice at postnatal day 5 (P5). Brains were dissected at humane endpoint. i Image of TP-Cherry/Venus-p27 organoid-derived brain tumor (n = 4 mice). j, k Image (j) and quantifications (k) of mCherry+ (red) and mVenus+ (green) cells not expressing Ki67 (gray) at infiltrating edge of organoid-derived tumors (n = 3 mice, 340 cells). l Principal Component Analysis of the transcriptomes of TP-induced tumors (M1 and M2) in mouse, TP-organoids grafts (O1, O2, O3, O4) and published human adult low- and high-grade glioma samples (oligodendroglioma, Oligoastrocytoma, astrocytoma and glioblastoma) and pediatric high-grade glioma samples. m Grafting of TP-Cherry/Venus-p27 organoids co-expressing or not DTA-p27 in the brains of nude mice. Brains were dissected at P21. n Images of TP-Cherry/Venus-p27 (without or with DTA-p27) organoid-derived brain tumors (n = 3 mice per condition). o Quantification of the distance of the infiltrated mCherry+ cells from the tumor edge in the brain sections of mice grafted with TP-Cherry/Venus-p27 without (n = 3 mice) or with DTA-p27 (n = 3 mice). The furthest three cells for each section were considered; each dot represents a cell and color code is applied to each mouse. Scale bars (b) 600 μm, (c, f, j) 100 μm, (I, n) 2 mm. Data are presented as mean ± SEM. P values were calculated by unpaired two-tailed Student’s t test (d, o). Source data are provided as a Source Data file.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/5a07e1e9be0d/41467_2022_32448_Fig5_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/5a07e1e9be0d/41467_2022_32448_Fig5_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/5a07e1e9be0d/41467_2022_32448_Fig5_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/5a07e1e9be0d/41467_2022_32448_Fig5_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig5",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/5a07e1e9be0d/41467_2022_32448_Fig5_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9378633/images/figure_5.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/5a07e1e9be0d/41467_2022_32448_Fig5_HTML.jpg"
    },
    "figure_6": {
      "figure_number": "Figure 6",
      "title": "Fig. 6. Pharmacological targeting of quiescent cells tested in human brain cancer organoids and GBM cell line reduces invasion.",
      "caption": "a TP-Cherry/Venus-p27 organoids at 30 dpe were treated with the listed drugs for 7 days. Organoids were live imaged at 0, 3 and 7 days of treatment. b Quantifications of mCherry+ and mVenus+ area and intensity at day 3 and day 7. Data were normalized to day 0. Each dot represents as single organoid (n = 11 organoids per condition). c Images of DMSO- or Harmine-treated organoids at day 0 and day 7 of treatment (n = 11 organoids per condition). d GB7 cells previously electroporated with pPB-CAG-mCherry (Cherry) and pPB-CAG-mVenus-p27K− (Venus-p27) were seeded one day prior treatment. Cells were treated with the listed drugs for 72 h and imaged every 24 h. Nuclei were counterstained with Hoechst for counting the number of nuclei. For each drug 3 wells were imaged, and experiments were conducted in duplicate. e Quantification of mVenus+/mCherry+ cells over the total of mCherry+ cells 24 h, 48 h and 72 h post treatment. Each dot represents a well (n = 6 wells per condition). Data were normalized on the DMSO-treated cells on the same day. f Images of DMSO- or Harmine-treated cells at 24 h, 48 h and 72 h post treatment (n = 54 images per condition). g GB7 cell-derived spheroids were embedded in collagen type I and live imaged at 0 h, 48 h and 72 h post embedding. Treatment with DMSO or Harmine started 2 days before embedding (Day 2 during spheroid formation). h, i Images (h) and quantifications (i) of spheroid invasion in the collagen matrix. Invasion was measured as increased area of mCherry+ cells from 0 h. Each dot represents a spheroid (n = 28 spheroids per condition). Data were normalized on the same spheroid at 0 h timepoint. Scale bars (c) 1 mm, (f) 400 μm, (h) 100 μm. Data are presented as mean ± SEM. P values were calculated by unpaired two-tailed non-parametric Mann–Whitney test or unpaired two-tailed Student’s t test (b, e, i) depending on whether data were normally distributed. Source data are provided as a Source Data file.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/8c6edaeb446b/41467_2022_32448_Fig6_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/8c6edaeb446b/41467_2022_32448_Fig6_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/8c6edaeb446b/41467_2022_32448_Fig6_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/8c6edaeb446b/41467_2022_32448_Fig6_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig6",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/8c6edaeb446b/41467_2022_32448_Fig6_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9378633/images/figure_6.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf80/9378633/8c6edaeb446b/41467_2022_32448_Fig6_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "To address whether a population of PROM1+ cells with quiescent feature exist in human brain cancer, we reanalyzed the single cell dataset15, consisting of the expression profiles of 7930 high-quality cells, 5742 from adult and 2188 from pediatric tumors (Fig. 1a).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among these cells, 6863 were defined as malignant based on the presence of chromosomal copy number aberrations15 (Fig. 1a).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "By measuring the expression of PROM1 in malignant cells, we observed higher levels in cells from pediatric glioblastomas (Fig. 1b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel b",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Based on the expression levels of known cell-cycle related genes, in particular two modules associated with G1/S and G2/M phases (Supplementary Fig. 1a–c, Methods), malignant cells were further classified into cycling and non-cycling (including quiescent cells), 3671 and 3192 respectively (Fig. 1d).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel d",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel d",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel d",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Combining this classification with the expression of PROM1, we identified a population of non-cycling PROM1+ cells, amounting to 11% of adult and 16% (313 cells) of pediatric malignant glioblastoma cells (Fig. 1e).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pediatric non-cycling PROM1+ cells were further classified according to the expression of other putative glioma stem cells marker such as SOX2 and OLIG2: 54% expressed both markers, 32% only SOX2, 6% only OLIG2, and 8% neither (Fig. 1e, right).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "To further characterize the population of 313 malignant non-cycling PROM1+ cells from pediatric glioblastomas, we compared their expression levels with 548 non-cycling PROM1- cells (Fig. 1f, upper panel, Supplementary Data 1), and with 523 cycling PROM1+ cells (Fig. 1f lower panel, Supplementary Data 2) and we identified specific sets of marker genes (Fig. 1g).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel f",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel f",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel g",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel g",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel g",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Cycling PROM1+ cells, when compared to non-cycling cells, displayed higher expression of genes related with cell cycle programs (Fig. 1h).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Importantly, non-cycling PROM1+ cells, compared to PROM1- cells, were characterized by high expression of genes associated with cell adhesion and spreading programs (Fig. 1i).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel i",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel i",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel i",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "We first validated the system in neural stem cells (NSCs) of normal mouse brain where mVenus-p27K− (Venus-p27) expression was controlled by the promoters of two genes expressed in quiescent stem cells: mouse Prom1 promoter14 (Prom1-Venus-p27) or human SOX2 promoter20 (Sox2-Venus-p27) (Supplementary Fig. 2a, b).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Afterwards, we confirmed the specificity of mouse Prom1 promoter by electroporating the cells in the subventricular zone (SVZ) of newborn Prom1-CreERT2 knock-in mice with two vectors expressing mVenus under the control of CreERT2 activity and mCherry expression under the control of Prom1 promoter, respectively (Supplementary Fig. 2c–e).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel c",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We also confirmed the specificity of the human SOX2 minimal promoter in targeting SOX2+ cells (Supplementary Fig. 2f, g).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel f",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We next checked whether the mVenus-p27K− biosensor labels quiescent Prom1+ or Sox2+ cells in the SVZ of mouse brain (Supplementary Fig. 3a).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "First, we found the absence of the proliferation marker Ki67 in 98.2% and 98.7% of Prom1-Venus-p27+ (qProm1) or Sox2-Venus-p27+(qSox2) cells (Supplementary Fig. 3b, c), respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Because cells in early G1 might not express high level of Ki67, we confirmed that qProm1 or qSox2 cells respectively did not incorporate 5-ethynyl-2′-deoxyuridine (EdU) when injected 24 h (Supplementary Fig. 3d-f) or 7 days (Supplementary Fig. 3g-i) prior to sacrifice.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel d",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "To do so, brain cancer was induced by overexpression of a ligand-independent form of human MET (TPR-MET) and mutant TP5321,22 (Fig. 2a).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We found that the combination of both TPR-MET and p53R273C (TP-Cherry) led to the formation of highly aggressive and lethal tumors (Fig. 2b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel b",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This was confirmed by RNA-seq analysis, showing high similarity to the transcriptomes of published mouse brain tumors23 (Supplementary Fig. 4a).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The co-expression of Prom1-Venus-p27 revealed the presence of qProm1 cells across the whole tumor as in tumor core and infiltrating edge (Fig. 2c, d).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel c",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Firstly, we found that the marker of proliferation Ki67 was not detected in 98.3% of qProm1 (Fig. 2d, e).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel d",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Similarly, 99.8% of qSox2 cells were negative for Ki67 (Supplementary Fig. 4b–d).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Furthermore, we confirmed that only 0.7% of qProm1 cells incorporated EdU within 24 h pulse period (Fig. 2f, g).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel f",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Afterwards, we confirmed that qProm1 (Fig. 2h–k) and also qSox2 (Supplementary Fig. 4e–h) cells expressed two non-specific glioma stem cell (GSC) markers such as SOX224 and OLIG225,26.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel h",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "We observed that about half of qProm1 cells express also SOX2, suggesting the possible co-existence of two different quiescent populations, Prom1+/SOX2+ and Prom1+/SOX2- (Fig. 2h, i), as also observed in human brain tumor samples (Fig. 1e). qProm1 (Fig. 2j, k) cells rarely expressed OLIG2 in the infiltrating edge.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel h",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel j",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The analysis of N-Cadherin expression together with the observation of cell shape suggests a mesenchymal-like morphology of qProm1 cells located in the infiltrating edge (Fig. 2l, Supplementary Movie 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Indeed, qProm1 cells showed a typical epithelial cobblestone morphology in the core, while they adopted an elongated shape with a strong accumulation of N-cadherin at the cell-cell contact in the infiltrating edge (Fig. 2l).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The specificity of the approach was confirmed by EdU incorporation demonstrating that our system labels cell progeny of quiescent cells (Supplementary Fig. 5a–c); moreover following lineage tracing 96.5% of qProm1-derived cells were positive for SOX2 in normal mouse SVZ (Supplementary Fig. 5d–f).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel d",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Mice were treated with Temozolomide (TMZ) for 5 days followed by 7 days labeling of qProm1 cells with Tamoxifen (Tam) (Fig. 3a).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Firstly, we confirmed lack of mVenus+ cells in absence of Tamoxifen (Supplementary Fig. 6a).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "To obtain an unbiased characterization, we analyzed the whole brain section, measuring the areas of brain (DAPI+) and tumor (mCherry+) (Fig. 3b and Supplementary Fig. 6b).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel b",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "As expected, we confirmed the efficacy of TMZ treatment on reducing tumor size, as well as the consequent fast relapse after chemotherapy administration (Fig. 3b).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In TMZ-treated mice, we did not observe significant differences with respect to the DMSO control group (Fig. 3c).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel c",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel c",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel c",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Interestingly, we did not observe any significant difference between DMSO or TMZ treatments (Fig. 3d, e and Supplementary Fig. 6c).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel d",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel c",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We rarely observed Venus+/NeuN+ and, as expected, they were mainly Ki67- (Supplementary Fig. 6d, e).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Furthermore, when we analyzed the proliferation rate of Venus+/Sox2+ cells, we observed they were mostly Ki67- with no difference with respect to both DMSO or TMZ groups (Supplementary Fig. 6f, g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel f",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We then analyzed the distribution of the glioma stem cell marker OLIG2 (Fig. 3f) observing a statistically significant increase only in the core of TMZ-treated mice over time (Fig. 3g).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel f",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel f",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel f",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The efficiency of ablation was verified in newborn SVZ with DTA-p27 (Supplementary Fig. 7a), revealing the absence of qProm1 cells (Supplementary Fig. 7b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "Panel a",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "Panel b",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "We also validated DTA-mediated ablation in qSox2 cells (Supplementary Fig. 7d-f).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "Panel d",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Afterwards we checked the presence of qProm1 cells in TP-induced tumors in absence or presence of DTA-p27 (Fig. 4a).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Mice were sacrificed at P45 and brain sections were histologically analyzed (Fig. 4b).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Compared to control mice, the co-injection of DTA-p27 led to an overall increased survival (median survival days: 56 for control vs 78 for +Prom1-DTA-p27 group) (Fig. 4c).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel c",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel c",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel c",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Furthermore, a reduced number of qProm1 cells (Fig. 4d) was accompanied with a smaller tumor size (Fig. 4e).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel d",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel d",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel d",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Interestingly, we also observed a strong reduction of tumor infiltrated cells (Fig. 4f).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel f",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel f",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel f",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "To investigate the effect of the depletion of qProm1 cells when the tumor is already formed, we electroporated newborn mice with TP-Cherry and with plasmids expressing DTA under the control of Prom1-CreERT2-p27K− (Fig. 4g).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "This enabled to control the DTA-mediated ablation of qProm1 cells by injection of Tamoxifen from P17 to P45 (Fig. 4g).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The analysis of brain sections confirmed a reduction of qProm1 population (Fig. 4h, i), but the tumor size was surprisingly increased (Fig. 4j) upon tamoxifen injection.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel h",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel j",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel j",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel j",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Interestingly, the ablation of qProm1 cells led to a reduction of infiltrating cells (Fig. 4k).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel k",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel k",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel k",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "TP-Cherry was electroporated in dorsal forebrain organoids differentiated from human induced pluripotent stem cells (hiPSCs) (Fig. 5a)27.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Live imaging of 30 days-post electroporation (30 dpe) organoids showed a more diffuse mCherry+ fluorescence compared with the control (Fig. 5b).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel b",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel b",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel b",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Histological characterization of the organoids confirmed that electroporation with TP-Cherry led to an increase in proliferating cells (Fig. 5c, d) as well as stem cell marker SOX2 (Supplementary Fig. 8a, b) and a reduction in neuronal marker NeuN (Supplementary Fig. 8c, d).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel c",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel a",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel c",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "To perform live imaging of the quiescent cells, we decided to drive Venus-p27expression under the control of a strong and ubiquitous promoter, such as CAG (Fig. 5e).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel e",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel e",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel e",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "We found that 89.2% of the quiescent mCherry+/mVenus+ cells co-expressed SOX2 (Supplementary Fig. 8e, f) and that 95.2% of mCherry+/mVenus+ cells were negative for proliferation marker Ki67 (Fig. 5f, g) confirming the visualization of slow-cycling/quiescent cells in brain cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel e",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel f",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Since we used an ubiquitous promoter, we showed that mVenus labels mainly SOX2+ or S100B+ progenitor cells (Supplementary Fig. 8e–h) and a few NeuN+ neuronal cells (Supplementary Fig. 8i, j).",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel e",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel i",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "We further characterized the infiltrative potential of those cells in vivo after grafting of TP-mCherry/mVenus-p27 electroporated organoids in the brain of nude mice (Fig. 5h–k, Supplementary Movie 2).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel h",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In addition, we confirmed in grafted organoids that Venus labels mainly S100B+ progenitor cells (Supplementary Fig. 8k, l) rather than NeuN+ neuronal cells (Supplementary Fig. 8m, n).",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel k",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel m",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Furthermore, we also compared the transcriptome profiles of TP organoid-derived tumors and TP-induced mouse tumors (Fig. 2) with human adult and pediatric low- and high-grade brain cancers (Fig. 5l).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Notably, both types of TP-induced tumors (organoid and mouse) clustered with pediatric high-grade glioma, with respect to other types of brain cancers (Fig. 5l).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Afterwards, we performed live imaging of TP-Cherry/Venus-p27 co-cultured with non-electroporated brain organoids (Host) (Supplementary Fig. 8o, p), which revealed the infiltration of mCherry+/mVenus+ cells.",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel o",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "We also confirmed the infiltration of mCherry+/mVenus+/Ki67- cells in the cryosections of the co-cultured organoids (Supplementary Fig. 8q, r).",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel q",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Finally, we grafted TP-organoids co-electroporated with DTA-p27 to assay the effect of ablating quiescent cells in the infiltration of TP-Cherry-derived cells (Fig. 5m).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel m",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel m",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel m",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The co-expression of DTA-p27 in TP-organoids led to a reduction in the infiltration of tumor cells (Fig. 5n, o).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel n",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "We treated TP-mCherry (+ Venus-p27) organoids with two DYRK1A/B inhibitors (AZ191 and Harmine) and other drugs previously used to ablate cell quiescence or to inhibit EMT30 (Fig. 6a).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Analysis of mCherry and mVenus positive area and intensity showed that Harmine and Simvastatin led to a reduction of mVenus signal compared with controls (Fig. 6b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel b",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We next tested the effects of the compounds on GB7 cancer stem cells (Fig. 6d, e and Supplementary Fig. 9a, b) and COMI cell lines (Supplementary Fig. 8c–g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 9",
          "panel": "Panel a",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel c",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "To do so, we electroporated both lines with the same pPB plasmids described in the manuscript encoding for mCherry and Venus-p27 to allow imaging and analysis of the change in cell number and impact of the drugs on quiescent cells (Fig. 6d).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We observed that Harmine consistently reduces quiescent cells when tested on both GB7 (Fig. 6e, f) and COMI (Supplementary Fig. 9c-g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel e",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 9",
          "panel": "Panel c",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "We next sought to test whether the treatment with Harmine, along with reducing quiescent cells, affects the invasiveness of GBM lines cancer stem cells (Fig. 6g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel g",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel g",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel g",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Here, we show that Harmine treatment is indeed able to reduce the degree of invasion of GB7 spheroids (Fig. 6h, i).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel h",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "To address whether a population of PROM1+ cells with quiescent feature exist in human brain cancer, we reanalyzed the single cell dataset15, consisting of the expression profiles of 7930 high-quality cells, 5742 from adult and 2188 from pediatric tumors (Fig. 1a).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among these cells, 6863 were defined as malignant based on the presence of chromosomal copy number aberrations15 (Fig. 1a).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "By measuring the expression of PROM1 in malignant cells, we observed higher levels in cells from pediatric glioblastomas (Fig. 1b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel b",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Based on the expression levels of known cell-cycle related genes, in particular two modules associated with G1/S and G2/M phases (Supplementary Fig. 1a–c, Methods), malignant cells were further classified into cycling and non-cycling (including quiescent cells), 3671 and 3192 respectively (Fig. 1d).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel d",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel d",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel d",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Combining this classification with the expression of PROM1, we identified a population of non-cycling PROM1+ cells, amounting to 11% of adult and 16% (313 cells) of pediatric malignant glioblastoma cells (Fig. 1e).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pediatric non-cycling PROM1+ cells were further classified according to the expression of other putative glioma stem cells marker such as SOX2 and OLIG2: 54% expressed both markers, 32% only SOX2, 6% only OLIG2, and 8% neither (Fig. 1e, right).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "To further characterize the population of 313 malignant non-cycling PROM1+ cells from pediatric glioblastomas, we compared their expression levels with 548 non-cycling PROM1- cells (Fig. 1f, upper panel, Supplementary Data 1), and with 523 cycling PROM1+ cells (Fig. 1f lower panel, Supplementary Data 2) and we identified specific sets of marker genes (Fig. 1g).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel f",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel f",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel g",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel g",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel g",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Cycling PROM1+ cells, when compared to non-cycling cells, displayed higher expression of genes related with cell cycle programs (Fig. 1h).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Importantly, non-cycling PROM1+ cells, compared to PROM1- cells, were characterized by high expression of genes associated with cell adhesion and spreading programs (Fig. 1i).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel i",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel i",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel i",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "To address whether a population of PROM1+ cells with quiescent feature exist in human brain cancer, we reanalyzed the single cell dataset15, consisting of the expression profiles of 7930 high-quality cells, 5742 from adult and 2188 from pediatric tumors (Fig. 1a).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Among these cells, 6863 were defined as malignant based on the presence of chromosomal copy number aberrations15 (Fig. 1a).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "By measuring the expression of PROM1 in malignant cells, we observed higher levels in cells from pediatric glioblastomas (Fig. 1b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel b",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Based on the expression levels of known cell-cycle related genes, in particular two modules associated with G1/S and G2/M phases (Supplementary Fig. 1a–c, Methods), malignant cells were further classified into cycling and non-cycling (including quiescent cells), 3671 and 3192 respectively (Fig. 1d).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel a",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel d",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel d",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel d",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Combining this classification with the expression of PROM1, we identified a population of non-cycling PROM1+ cells, amounting to 11% of adult and 16% (313 cells) of pediatric malignant glioblastoma cells (Fig. 1e).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pediatric non-cycling PROM1+ cells were further classified according to the expression of other putative glioma stem cells marker such as SOX2 and OLIG2: 54% expressed both markers, 32% only SOX2, 6% only OLIG2, and 8% neither (Fig. 1e, right).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "To further characterize the population of 313 malignant non-cycling PROM1+ cells from pediatric glioblastomas, we compared their expression levels with 548 non-cycling PROM1- cells (Fig. 1f, upper panel, Supplementary Data 1), and with 523 cycling PROM1+ cells (Fig. 1f lower panel, Supplementary Data 2) and we identified specific sets of marker genes (Fig. 1g).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel f",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel f",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel g",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel g",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel g",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Cycling PROM1+ cells, when compared to non-cycling cells, displayed higher expression of genes related with cell cycle programs (Fig. 1h).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Importantly, non-cycling PROM1+ cells, compared to PROM1- cells, were characterized by high expression of genes associated with cell adhesion and spreading programs (Fig. 1i).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel i",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel i",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel i",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "We first validated the system in neural stem cells (NSCs) of normal mouse brain where mVenus-p27K− (Venus-p27) expression was controlled by the promoters of two genes expressed in quiescent stem cells: mouse Prom1 promoter14 (Prom1-Venus-p27) or human SOX2 promoter20 (Sox2-Venus-p27) (Supplementary Fig. 2a, b).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Afterwards, we confirmed the specificity of mouse Prom1 promoter by electroporating the cells in the subventricular zone (SVZ) of newborn Prom1-CreERT2 knock-in mice with two vectors expressing mVenus under the control of CreERT2 activity and mCherry expression under the control of Prom1 promoter, respectively (Supplementary Fig. 2c–e).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel c",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We also confirmed the specificity of the human SOX2 minimal promoter in targeting SOX2+ cells (Supplementary Fig. 2f, g).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel f",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We next checked whether the mVenus-p27K− biosensor labels quiescent Prom1+ or Sox2+ cells in the SVZ of mouse brain (Supplementary Fig. 3a).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "First, we found the absence of the proliferation marker Ki67 in 98.2% and 98.7% of Prom1-Venus-p27+ (qProm1) or Sox2-Venus-p27+(qSox2) cells (Supplementary Fig. 3b, c), respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Because cells in early G1 might not express high level of Ki67, we confirmed that qProm1 or qSox2 cells respectively did not incorporate 5-ethynyl-2′-deoxyuridine (EdU) when injected 24 h (Supplementary Fig. 3d-f) or 7 days (Supplementary Fig. 3g-i) prior to sacrifice.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel d",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "To do so, brain cancer was induced by overexpression of a ligand-independent form of human MET (TPR-MET) and mutant TP5321,22 (Fig. 2a).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We found that the combination of both TPR-MET and p53R273C (TP-Cherry) led to the formation of highly aggressive and lethal tumors (Fig. 2b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel b",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This was confirmed by RNA-seq analysis, showing high similarity to the transcriptomes of published mouse brain tumors23 (Supplementary Fig. 4a).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The co-expression of Prom1-Venus-p27 revealed the presence of qProm1 cells across the whole tumor as in tumor core and infiltrating edge (Fig. 2c, d).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel c",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Firstly, we found that the marker of proliferation Ki67 was not detected in 98.3% of qProm1 (Fig. 2d, e).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel d",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Similarly, 99.8% of qSox2 cells were negative for Ki67 (Supplementary Fig. 4b–d).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Furthermore, we confirmed that only 0.7% of qProm1 cells incorporated EdU within 24 h pulse period (Fig. 2f, g).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel f",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Afterwards, we confirmed that qProm1 (Fig. 2h–k) and also qSox2 (Supplementary Fig. 4e–h) cells expressed two non-specific glioma stem cell (GSC) markers such as SOX224 and OLIG225,26.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel h",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "We observed that about half of qProm1 cells express also SOX2, suggesting the possible co-existence of two different quiescent populations, Prom1+/SOX2+ and Prom1+/SOX2- (Fig. 2h, i), as also observed in human brain tumor samples (Fig. 1e). qProm1 (Fig. 2j, k) cells rarely expressed OLIG2 in the infiltrating edge.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel h",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel j",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The analysis of N-Cadherin expression together with the observation of cell shape suggests a mesenchymal-like morphology of qProm1 cells located in the infiltrating edge (Fig. 2l, Supplementary Movie 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Indeed, qProm1 cells showed a typical epithelial cobblestone morphology in the core, while they adopted an elongated shape with a strong accumulation of N-cadherin at the cell-cell contact in the infiltrating edge (Fig. 2l).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We first validated the system in neural stem cells (NSCs) of normal mouse brain where mVenus-p27K− (Venus-p27) expression was controlled by the promoters of two genes expressed in quiescent stem cells: mouse Prom1 promoter14 (Prom1-Venus-p27) or human SOX2 promoter20 (Sox2-Venus-p27) (Supplementary Fig. 2a, b).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Afterwards, we confirmed the specificity of mouse Prom1 promoter by electroporating the cells in the subventricular zone (SVZ) of newborn Prom1-CreERT2 knock-in mice with two vectors expressing mVenus under the control of CreERT2 activity and mCherry expression under the control of Prom1 promoter, respectively (Supplementary Fig. 2c–e).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel c",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We also confirmed the specificity of the human SOX2 minimal promoter in targeting SOX2+ cells (Supplementary Fig. 2f, g).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel f",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We next checked whether the mVenus-p27K− biosensor labels quiescent Prom1+ or Sox2+ cells in the SVZ of mouse brain (Supplementary Fig. 3a).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "First, we found the absence of the proliferation marker Ki67 in 98.2% and 98.7% of Prom1-Venus-p27+ (qProm1) or Sox2-Venus-p27+(qSox2) cells (Supplementary Fig. 3b, c), respectively.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Because cells in early G1 might not express high level of Ki67, we confirmed that qProm1 or qSox2 cells respectively did not incorporate 5-ethynyl-2′-deoxyuridine (EdU) when injected 24 h (Supplementary Fig. 3d-f) or 7 days (Supplementary Fig. 3g-i) prior to sacrifice.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel d",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "To do so, brain cancer was induced by overexpression of a ligand-independent form of human MET (TPR-MET) and mutant TP5321,22 (Fig. 2a).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "We found that the combination of both TPR-MET and p53R273C (TP-Cherry) led to the formation of highly aggressive and lethal tumors (Fig. 2b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel b",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This was confirmed by RNA-seq analysis, showing high similarity to the transcriptomes of published mouse brain tumors23 (Supplementary Fig. 4a).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The co-expression of Prom1-Venus-p27 revealed the presence of qProm1 cells across the whole tumor as in tumor core and infiltrating edge (Fig. 2c, d).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel c",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Firstly, we found that the marker of proliferation Ki67 was not detected in 98.3% of qProm1 (Fig. 2d, e).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel d",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Similarly, 99.8% of qSox2 cells were negative for Ki67 (Supplementary Fig. 4b–d).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Furthermore, we confirmed that only 0.7% of qProm1 cells incorporated EdU within 24 h pulse period (Fig. 2f, g).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel f",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Afterwards, we confirmed that qProm1 (Fig. 2h–k) and also qSox2 (Supplementary Fig. 4e–h) cells expressed two non-specific glioma stem cell (GSC) markers such as SOX224 and OLIG225,26.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel h",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "We observed that about half of qProm1 cells express also SOX2, suggesting the possible co-existence of two different quiescent populations, Prom1+/SOX2+ and Prom1+/SOX2- (Fig. 2h, i), as also observed in human brain tumor samples (Fig. 1e). qProm1 (Fig. 2j, k) cells rarely expressed OLIG2 in the infiltrating edge.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel h",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel j",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "Panel e",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The analysis of N-Cadherin expression together with the observation of cell shape suggests a mesenchymal-like morphology of qProm1 cells located in the infiltrating edge (Fig. 2l, Supplementary Movie 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Indeed, qProm1 cells showed a typical epithelial cobblestone morphology in the core, while they adopted an elongated shape with a strong accumulation of N-cadherin at the cell-cell contact in the infiltrating edge (Fig. 2l).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel l",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The specificity of the approach was confirmed by EdU incorporation demonstrating that our system labels cell progeny of quiescent cells (Supplementary Fig. 5a–c); moreover following lineage tracing 96.5% of qProm1-derived cells were positive for SOX2 in normal mouse SVZ (Supplementary Fig. 5d–f).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel d",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Mice were treated with Temozolomide (TMZ) for 5 days followed by 7 days labeling of qProm1 cells with Tamoxifen (Tam) (Fig. 3a).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Firstly, we confirmed lack of mVenus+ cells in absence of Tamoxifen (Supplementary Fig. 6a).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "To obtain an unbiased characterization, we analyzed the whole brain section, measuring the areas of brain (DAPI+) and tumor (mCherry+) (Fig. 3b and Supplementary Fig. 6b).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel b",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "As expected, we confirmed the efficacy of TMZ treatment on reducing tumor size, as well as the consequent fast relapse after chemotherapy administration (Fig. 3b).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In TMZ-treated mice, we did not observe significant differences with respect to the DMSO control group (Fig. 3c).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel c",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel c",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel c",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Interestingly, we did not observe any significant difference between DMSO or TMZ treatments (Fig. 3d, e and Supplementary Fig. 6c).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel d",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel c",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We rarely observed Venus+/NeuN+ and, as expected, they were mainly Ki67- (Supplementary Fig. 6d, e).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Furthermore, when we analyzed the proliferation rate of Venus+/Sox2+ cells, we observed they were mostly Ki67- with no difference with respect to both DMSO or TMZ groups (Supplementary Fig. 6f, g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel f",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We then analyzed the distribution of the glioma stem cell marker OLIG2 (Fig. 3f) observing a statistically significant increase only in the core of TMZ-treated mice over time (Fig. 3g).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel f",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel f",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel f",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The specificity of the approach was confirmed by EdU incorporation demonstrating that our system labels cell progeny of quiescent cells (Supplementary Fig. 5a–c); moreover following lineage tracing 96.5% of qProm1-derived cells were positive for SOX2 in normal mouse SVZ (Supplementary Fig. 5d–f).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel d",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Mice were treated with Temozolomide (TMZ) for 5 days followed by 7 days labeling of qProm1 cells with Tamoxifen (Tam) (Fig. 3a).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Firstly, we confirmed lack of mVenus+ cells in absence of Tamoxifen (Supplementary Fig. 6a).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "To obtain an unbiased characterization, we analyzed the whole brain section, measuring the areas of brain (DAPI+) and tumor (mCherry+) (Fig. 3b and Supplementary Fig. 6b).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel b",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "As expected, we confirmed the efficacy of TMZ treatment on reducing tumor size, as well as the consequent fast relapse after chemotherapy administration (Fig. 3b).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel b",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In TMZ-treated mice, we did not observe significant differences with respect to the DMSO control group (Fig. 3c).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel c",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel c",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel c",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Interestingly, we did not observe any significant difference between DMSO or TMZ treatments (Fig. 3d, e and Supplementary Fig. 6c).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel d",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel c",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We rarely observed Venus+/NeuN+ and, as expected, they were mainly Ki67- (Supplementary Fig. 6d, e).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Furthermore, when we analyzed the proliferation rate of Venus+/Sox2+ cells, we observed they were mostly Ki67- with no difference with respect to both DMSO or TMZ groups (Supplementary Fig. 6f, g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel f",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We then analyzed the distribution of the glioma stem cell marker OLIG2 (Fig. 3f) observing a statistically significant increase only in the core of TMZ-treated mice over time (Fig. 3g).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "Panel f",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel f",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel f",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel g",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The efficiency of ablation was verified in newborn SVZ with DTA-p27 (Supplementary Fig. 7a), revealing the absence of qProm1 cells (Supplementary Fig. 7b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "Panel a",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "Panel b",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "We also validated DTA-mediated ablation in qSox2 cells (Supplementary Fig. 7d-f).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "Panel d",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Afterwards we checked the presence of qProm1 cells in TP-induced tumors in absence or presence of DTA-p27 (Fig. 4a).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Mice were sacrificed at P45 and brain sections were histologically analyzed (Fig. 4b).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Compared to control mice, the co-injection of DTA-p27 led to an overall increased survival (median survival days: 56 for control vs 78 for +Prom1-DTA-p27 group) (Fig. 4c).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel c",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel c",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel c",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Furthermore, a reduced number of qProm1 cells (Fig. 4d) was accompanied with a smaller tumor size (Fig. 4e).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel d",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel d",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel d",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Interestingly, we also observed a strong reduction of tumor infiltrated cells (Fig. 4f).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel f",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel f",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel f",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "To investigate the effect of the depletion of qProm1 cells when the tumor is already formed, we electroporated newborn mice with TP-Cherry and with plasmids expressing DTA under the control of Prom1-CreERT2-p27K− (Fig. 4g).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "This enabled to control the DTA-mediated ablation of qProm1 cells by injection of Tamoxifen from P17 to P45 (Fig. 4g).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The analysis of brain sections confirmed a reduction of qProm1 population (Fig. 4h, i), but the tumor size was surprisingly increased (Fig. 4j) upon tamoxifen injection.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel h",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel j",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel j",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel j",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Interestingly, the ablation of qProm1 cells led to a reduction of infiltrating cells (Fig. 4k).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel k",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel k",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel k",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The efficiency of ablation was verified in newborn SVZ with DTA-p27 (Supplementary Fig. 7a), revealing the absence of qProm1 cells (Supplementary Fig. 7b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "Panel a",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "Panel b",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "We also validated DTA-mediated ablation in qSox2 cells (Supplementary Fig. 7d-f).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "Panel d",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Afterwards we checked the presence of qProm1 cells in TP-induced tumors in absence or presence of DTA-p27 (Fig. 4a).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Mice were sacrificed at P45 and brain sections were histologically analyzed (Fig. 4b).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel b",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Compared to control mice, the co-injection of DTA-p27 led to an overall increased survival (median survival days: 56 for control vs 78 for +Prom1-DTA-p27 group) (Fig. 4c).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel c",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel c",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel c",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Furthermore, a reduced number of qProm1 cells (Fig. 4d) was accompanied with a smaller tumor size (Fig. 4e).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel d",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel d",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel d",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel e",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Interestingly, we also observed a strong reduction of tumor infiltrated cells (Fig. 4f).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel f",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel f",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel f",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "To investigate the effect of the depletion of qProm1 cells when the tumor is already formed, we electroporated newborn mice with TP-Cherry and with plasmids expressing DTA under the control of Prom1-CreERT2-p27K− (Fig. 4g).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "This enabled to control the DTA-mediated ablation of qProm1 cells by injection of Tamoxifen from P17 to P45 (Fig. 4g).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel g",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The analysis of brain sections confirmed a reduction of qProm1 population (Fig. 4h, i), but the tumor size was surprisingly increased (Fig. 4j) upon tamoxifen injection.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel h",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel j",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel j",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel j",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Interestingly, the ablation of qProm1 cells led to a reduction of infiltrating cells (Fig. 4k).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "Panel k",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel k",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel k",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "TP-Cherry was electroporated in dorsal forebrain organoids differentiated from human induced pluripotent stem cells (hiPSCs) (Fig. 5a)27.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Live imaging of 30 days-post electroporation (30 dpe) organoids showed a more diffuse mCherry+ fluorescence compared with the control (Fig. 5b).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel b",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel b",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel b",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Histological characterization of the organoids confirmed that electroporation with TP-Cherry led to an increase in proliferating cells (Fig. 5c, d) as well as stem cell marker SOX2 (Supplementary Fig. 8a, b) and a reduction in neuronal marker NeuN (Supplementary Fig. 8c, d).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel c",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel a",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel c",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "To perform live imaging of the quiescent cells, we decided to drive Venus-p27expression under the control of a strong and ubiquitous promoter, such as CAG (Fig. 5e).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel e",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel e",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel e",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "We found that 89.2% of the quiescent mCherry+/mVenus+ cells co-expressed SOX2 (Supplementary Fig. 8e, f) and that 95.2% of mCherry+/mVenus+ cells were negative for proliferation marker Ki67 (Fig. 5f, g) confirming the visualization of slow-cycling/quiescent cells in brain cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel e",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel f",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Since we used an ubiquitous promoter, we showed that mVenus labels mainly SOX2+ or S100B+ progenitor cells (Supplementary Fig. 8e–h) and a few NeuN+ neuronal cells (Supplementary Fig. 8i, j).",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel e",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel i",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "We further characterized the infiltrative potential of those cells in vivo after grafting of TP-mCherry/mVenus-p27 electroporated organoids in the brain of nude mice (Fig. 5h–k, Supplementary Movie 2).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel h",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In addition, we confirmed in grafted organoids that Venus labels mainly S100B+ progenitor cells (Supplementary Fig. 8k, l) rather than NeuN+ neuronal cells (Supplementary Fig. 8m, n).",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel k",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel m",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Furthermore, we also compared the transcriptome profiles of TP organoid-derived tumors and TP-induced mouse tumors (Fig. 2) with human adult and pediatric low- and high-grade brain cancers (Fig. 5l).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Notably, both types of TP-induced tumors (organoid and mouse) clustered with pediatric high-grade glioma, with respect to other types of brain cancers (Fig. 5l).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Afterwards, we performed live imaging of TP-Cherry/Venus-p27 co-cultured with non-electroporated brain organoids (Host) (Supplementary Fig. 8o, p), which revealed the infiltration of mCherry+/mVenus+ cells.",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel o",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "We also confirmed the infiltration of mCherry+/mVenus+/Ki67- cells in the cryosections of the co-cultured organoids (Supplementary Fig. 8q, r).",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel q",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Finally, we grafted TP-organoids co-electroporated with DTA-p27 to assay the effect of ablating quiescent cells in the infiltration of TP-Cherry-derived cells (Fig. 5m).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel m",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel m",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel m",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The co-expression of DTA-p27 in TP-organoids led to a reduction in the infiltration of tumor cells (Fig. 5n, o).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel n",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "TP-Cherry was electroporated in dorsal forebrain organoids differentiated from human induced pluripotent stem cells (hiPSCs) (Fig. 5a)27.",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel a",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Live imaging of 30 days-post electroporation (30 dpe) organoids showed a more diffuse mCherry+ fluorescence compared with the control (Fig. 5b).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel b",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel b",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel b",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Histological characterization of the organoids confirmed that electroporation with TP-Cherry led to an increase in proliferating cells (Fig. 5c, d) as well as stem cell marker SOX2 (Supplementary Fig. 8a, b) and a reduction in neuronal marker NeuN (Supplementary Fig. 8c, d).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel c",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel a",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel c",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "To perform live imaging of the quiescent cells, we decided to drive Venus-p27expression under the control of a strong and ubiquitous promoter, such as CAG (Fig. 5e).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel e",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel e",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel e",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "We found that 89.2% of the quiescent mCherry+/mVenus+ cells co-expressed SOX2 (Supplementary Fig. 8e, f) and that 95.2% of mCherry+/mVenus+ cells were negative for proliferation marker Ki67 (Fig. 5f, g) confirming the visualization of slow-cycling/quiescent cells in brain cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel e",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel f",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Since we used an ubiquitous promoter, we showed that mVenus labels mainly SOX2+ or S100B+ progenitor cells (Supplementary Fig. 8e–h) and a few NeuN+ neuronal cells (Supplementary Fig. 8i, j).",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel e",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel i",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "We further characterized the infiltrative potential of those cells in vivo after grafting of TP-mCherry/mVenus-p27 electroporated organoids in the brain of nude mice (Fig. 5h–k, Supplementary Movie 2).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel h",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In addition, we confirmed in grafted organoids that Venus labels mainly S100B+ progenitor cells (Supplementary Fig. 8k, l) rather than NeuN+ neuronal cells (Supplementary Fig. 8m, n).",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel k",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel m",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Furthermore, we also compared the transcriptome profiles of TP organoid-derived tumors and TP-induced mouse tumors (Fig. 2) with human adult and pediatric low- and high-grade brain cancers (Fig. 5l).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Notably, both types of TP-induced tumors (organoid and mouse) clustered with pediatric high-grade glioma, with respect to other types of brain cancers (Fig. 5l).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel l",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Afterwards, we performed live imaging of TP-Cherry/Venus-p27 co-cultured with non-electroporated brain organoids (Host) (Supplementary Fig. 8o, p), which revealed the infiltration of mCherry+/mVenus+ cells.",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel o",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "We also confirmed the infiltration of mCherry+/mVenus+/Ki67- cells in the cryosections of the co-cultured organoids (Supplementary Fig. 8q, r).",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "Panel q",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Finally, we grafted TP-organoids co-electroporated with DTA-p27 to assay the effect of ablating quiescent cells in the infiltration of TP-Cherry-derived cells (Fig. 5m).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel m",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel m",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel m",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "The co-expression of DTA-p27 in TP-organoids led to a reduction in the infiltration of tumor cells (Fig. 5n, o).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "Panel n",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "We treated TP-mCherry (+ Venus-p27) organoids with two DYRK1A/B inhibitors (AZ191 and Harmine) and other drugs previously used to ablate cell quiescence or to inhibit EMT30 (Fig. 6a).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Analysis of mCherry and mVenus positive area and intensity showed that Harmine and Simvastatin led to a reduction of mVenus signal compared with controls (Fig. 6b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel b",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We next tested the effects of the compounds on GB7 cancer stem cells (Fig. 6d, e and Supplementary Fig. 9a, b) and COMI cell lines (Supplementary Fig. 8c–g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 9",
          "panel": "Panel a",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel c",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "To do so, we electroporated both lines with the same pPB plasmids described in the manuscript encoding for mCherry and Venus-p27 to allow imaging and analysis of the change in cell number and impact of the drugs on quiescent cells (Fig. 6d).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We observed that Harmine consistently reduces quiescent cells when tested on both GB7 (Fig. 6e, f) and COMI (Supplementary Fig. 9c-g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel e",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 9",
          "panel": "Panel c",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "We next sought to test whether the treatment with Harmine, along with reducing quiescent cells, affects the invasiveness of GBM lines cancer stem cells (Fig. 6g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel g",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel g",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel g",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Here, we show that Harmine treatment is indeed able to reduce the degree of invasion of GB7 spheroids (Fig. 6h, i).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel h",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We treated TP-mCherry (+ Venus-p27) organoids with two DYRK1A/B inhibitors (AZ191 and Harmine) and other drugs previously used to ablate cell quiescence or to inhibit EMT30 (Fig. 6a).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Analysis of mCherry and mVenus positive area and intensity showed that Harmine and Simvastatin led to a reduction of mVenus signal compared with controls (Fig. 6b, c).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel b",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We next tested the effects of the compounds on GB7 cancer stem cells (Fig. 6d, e and Supplementary Fig. 9a, b) and COMI cell lines (Supplementary Fig. 8c–g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 9",
          "panel": "Panel a",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 8",
          "panel": "Panel c",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "To do so, we electroporated both lines with the same pPB plasmids described in the manuscript encoding for mCherry and Venus-p27 to allow imaging and analysis of the change in cell number and impact of the drugs on quiescent cells (Fig. 6d).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "We observed that Harmine consistently reduces quiescent cells when tested on both GB7 (Fig. 6e, f) and COMI (Supplementary Fig. 9c-g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel e",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 9",
          "panel": "Panel c",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "We next sought to test whether the treatment with Harmine, along with reducing quiescent cells, affects the invasiveness of GBM lines cancer stem cells (Fig. 6g).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel g",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel g",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel g",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Here, we show that Harmine treatment is indeed able to reduce the degree of invasion of GB7 spheroids (Fig. 6h, i).",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel h",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The system we conceived to specifically perform a CEll cycle-based Lineage Tracing and Ablation (CELTA) (Supplementary Fig. 10a, b) allowed us to reveal how qProm1+ cells contribute to the tumor infiltration (Supplementary Fig. 10c).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "Panel a",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "Panel c",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The system we conceived to specifically perform a CEll cycle-based Lineage Tracing and Ablation (CELTA) (Supplementary Fig. 10a, b) allowed us to reveal how qProm1+ cells contribute to the tumor infiltration (Supplementary Fig. 10c).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "Panel a",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "Panel c",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The concentrations used in the experiments are stated in Fig. 6a.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "On day 0, medium supplemented with the aforementioned drugs (Fig. 6d) was replaced to each well and changed every 48 h.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "The concentrations used in the experiments are stated in Fig. 6a.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel a",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "On day 0, medium supplemented with the aforementioned drugs (Fig. 6d) was replaced to each well and changed every 48 h.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "Panel d",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "L.T. created Fig. 1h (brain drawing), Fig. 2a, Fig. 3a, Fig. 4a, Fig. 5h, m.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel h",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "L.T. created Fig. 1h (brain drawing), Fig. 2a, Fig. 3a, Fig. 4a, Fig. 5h, m.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "Panel h",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "Panel a",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 3",
          "panel": "Panel a",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 4",
          "panel": "Panel a",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 5",
          "panel": "Panel h",
          "figure_key": "figure_5"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 6,
    "claims_count": 212,
    "images_downloaded": 6,
    "tables_filtered": 3
  }
}